RESUMO
A new strategy to prepare copper (Cu) nanoparticles anchored in nitrogen-doped carbon nanosheets (Cu@CN) has been designed and the nanomaterial applied to the determination of paraquat (PQ). The nanocomposite materials were characterized by transmission electron microscopy (TEM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and several other techniques. We found that the Cu nanoparticles are uniformly distributed on the carbon materials, providing abundant active sites for electrochemical detection. The electrochemical behavior of the Cu@CN-based PQ sensor was investigated by square-wave voltammetry (SWV). Cu@CN exhibited excellent electrochemical activity and PQ detection performance. The Cu@CN-modified glassy carbon electrode (Cu@CN/GCE) exhibited excellent stability, favorable sensitivity, and high selectivity under optimized conditions (enrichment voltage -0.1 V and enrichment time 400 s) of the SWV test. The detection range reached 0.50 nM to 12.00 µM, and the limit of detection was 0.43 nM with high sensitivity of 18 µA·µM-1·cm-2. The detection limit is 9 times better than that of the high-performance liquid chromatography method. The Cu@CN electrochemical sensor demonstrated excellent sensitivity and selectivity also in environmental water and fruit samples enabling its use in practical, rapid trace-level detection of PQ in environmental samples.
RESUMO
Capturing CO2 has become increasingly important. However, wide industrial applications of conventional CO2 capture technologies are limited by their slow CO2 sorption and desorption kinetics. Accordingly, this research is designed to overcome the challenge by synthesizing mesoporous MgO nanoparticles (MgO-NPs) with a new method that uses PEG 1500 as a soft template. MgO surface structure is nonstoichiometric due to its distinctive shape; the abundant Lewis base sites provided by oxygen vacancies promote CO2 capture. Adding 2 wt % MgO-NPs to 20 wt % monoethanolamine (MEA) can increase the breakthrough time (the time with 90% CO2 capturing efficiency) by â¼3000% and can increase the CO2 absorption capacity within the breakthrough time by â¼3660%. The data suggest that MgO-NPs can accelerate the rate and increase CO2 desorption capacity by up to â¼8740% and â¼2290% at 90 °C, respectively. Also, the excellent stability of the system within 50 cycles is verified. These findings demonstrate a new strategy to innovate MEA absorbents currently widely used in commercial post-combustion CO2 capture plants.
Assuntos
Dióxido de Carbono , Óxido de Magnésio , Dióxido de Carbono/química , Óxido de Magnésio/química , Bases de Lewis , Etanolamina/química , CinéticaRESUMO
Coronary microvascular endothelial dysfunction is both a culprit and a victim of diabetes, and can accelerate diabetes-related microvascular and macrovascular complications by promoting vasoconstrictive, pro-inflammatory and pro-thrombotic responses. Perturbed mitochondrial function induces oxidative stress, disrupts metabolism and activates apoptosis in endothelial cells, thus exacerbating the progression of coronary microvascular complications in diabetes. The mitochondrial quality surveillance (MQS) system responds to stress by altering mitochondrial metabolism, dynamics (fission and fusion), mitophagy and biogenesis. Dysfunctional mitochondria are prone to fission, which generates two distinct types of mitochondria: one with a normal and the other with a depolarized mitochondrial membrane potential. Mitochondrial fusion and mitophagy can restore the membrane potential and homeostasis of defective mitochondrial fragments. Mitophagy-induced decreases in the mitochondrial population can be reversed by mitochondrial biogenesis. MQS abnormalities induce pathological mitochondrial fission, delayed mitophagy, impaired metabolism and defective biogenesis, thus promoting the accumulation of unhealthy mitochondria and the activation of mitochondria-dependent apoptosis. In this review, we examine the effects of MQS on mitochondrial fitness and explore the association of MQS disorders with coronary microvascular endothelial dysfunction in diabetes. We also discuss the potential to treat diabetes-related coronary microvascular endothelial dysfunction using novel MQS-altering drugs.
Assuntos
Diabetes Mellitus , Células Endoteliais , Diabetes Mellitus/metabolismo , Células Endoteliais/metabolismo , Humanos , Mitocôndrias/metabolismo , Dinâmica Mitocondrial/fisiologia , Mitofagia/fisiologiaRESUMO
Carbon dioxide (CO2) emissions from fossil fuel combustion have been linked to increased average global temperatures, a global challenge for many decades. Mitigating CO2 concentration in the atmosphere is a priority for the protection of the environment. This is a comparison of the three main technological categories available for CO2 capture and storage. They include: oxy-fuel combustion, pre-combustion, and post-combustion. Each capture technology has inherent benefits and disadvantages in cost, implementation, and flexibility, but post-combustion CO2 capture has demonstrated the most promising results in typical power plant configurations. This paper presents a review of different post-combustion CO2 capture materials; solvents, membranes, and adsorbents, focusing on economical and environmentally safe low to high temperature solid adsorbents. Furthermore, the authors summarize the advantages and limitations of the materials investigated to provide insight into the challenges and opportunities currently facing the development of post-combustion CO2 capture technologies. The solid sorbents currently available for CO2 capture are also reviewed in detail, including physical and chemical properties, reactions, and current research efforts on improvement.
Assuntos
Dióxido de Carbono , Combustíveis Fósseis , Adsorção , Dióxido de Carbono/análise , Centrais Elétricas , TemperaturaRESUMO
As reperfusion therapies have become more widely used in acute myocardial infarction patients, ischemia-induced myocardial damage has been markedly reduced, but reperfusion-induced cardiac injury has become increasingly evident. The features of cardiac ischemia-reperfusion (I/R) injury include microvascular perfusion defects, platelet activation and sequential cardiomyocyte death due to additional ischemic events at the reperfusion stage. Microvascular obstruction, defined as a no-reflow phenomenon, determines the infarct zone, myocardial function and peri-operative mortality. Cardiac microvascular endothelial cell injury may occur much earlier and with much greater severity than cardiomyocyte injury. Endothelial cells contain fewer mitochondria than other cardiac cells, and several of the pathological alterations during cardiac microvascular I/R injury involve mitochondria, such as increased mitochondrial reactive oxygen species (mROS) levels and disturbed mitochondrial dynamics. Although mROS are necessary physiological second messengers, high mROS levels induce oxidative stress, endothelial senescence and apoptosis. Mitochondrial dynamics, including fission, fusion and mitophagy, determine the shape, distribution, size and function of mitochondria. These adaptive responses modify extracellular signals and orchestrate intracellular processes such as cell proliferation, migration, metabolism, angiogenesis, permeability transition, adhesive molecule expression, endothelial barrier function and anticoagulation. In this review, we discuss the involvement of mROS and mitochondrial morphofunction in cardiac microvascular I/R injury.
Assuntos
Mitocôndrias Cardíacas , Dinâmica Mitocondrial , Traumatismo por Reperfusão Miocárdica , Animais , Células Endoteliais/metabolismo , Masculino , Mitocôndrias Cardíacas/metabolismo , Mitocôndrias Cardíacas/patologia , Traumatismo por Reperfusão Miocárdica/metabolismo , Traumatismo por Reperfusão Miocárdica/patologiaRESUMO
Since the publication of the article, the authors found a small problem with Fig. 7e. Unfortunately, Fig. 7e did not contain the correct images. The correct images are shown below and do not change the conclusions.
RESUMO
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a novel inducer to promote mitochondrial apoptosis and suppress tumor growth in a variety of cells although its role in cardiovascular diseases remains obscure. This study was designed to examine the role of DNA-PKcs in cardiac ischemia reperfusion (IR) injury and mitochondrial damage. Cardiomyocyte-specific DNA-PKcs knockout (DNA-PKcsCKO) mice were subjected to IR prior to assessment of myocardial function and mitochondrial apoptosis. Our data revealed that IR challenge, hypoxia-reoxygenation (HR) or H2O2-activated DNA-PKcs through post-transcriptional phosphorylation in murine hearts or cardiomyocytes. Mice deficient in DNA-PKcs in cardiomyocytes were protected against cardiomyocyte death, infarct area expansion and cardiac dysfunction. DNA-PKcs ablation countered IR- or HR-induced oxidative stress, mPTP opening, mitochondrial fission, mitophagy failure and Bax-mediated mitochondrial apoptosis, possibly through suppression of Bax inhibitor-1 (BI-1) activity. A direct association between DNA-PKcs and BI-1 was noted where DNA-PKcs had little effect on BI-1 transcription but interacted with BI-1 to promote its degradation. Loss of DNA-PKcs stabilized BI-1, thus offering resistance of mitochondria and cardiomyocytes against IR insult. Moreover, DNA-PKcs ablation-induced beneficial cardioprotection against IR injury was mitigated by concurrent knockout of BI-1. Double deletion of DNA-PKcs and BI-1 failed to exert protection against global IR injury and mitochondrial damage, confirming a permissive role of BI-1 in DNA-PKcs deletion-elicited cardioprotection against IR injury. DNA-PKcs serves as a novel causative factor for mitochondrial damage via suppression of BI-1, en route to the onset and development of cardiac IR injury.
Assuntos
Apoptose , Proteína Quinase Ativada por DNA/metabolismo , Proteínas de Ligação a DNA/metabolismo , Proteínas de Membrana/metabolismo , Mitocôndrias Cardíacas/enzimologia , Infarto do Miocárdio/enzimologia , Traumatismo por Reperfusão Miocárdica/enzimologia , Miócitos Cardíacos/enzimologia , Animais , Células Cultivadas , Proteína Quinase Ativada por DNA/deficiência , Proteína Quinase Ativada por DNA/genética , Proteínas de Ligação a DNA/deficiência , Proteínas de Ligação a DNA/genética , Modelos Animais de Doenças , Homeostase , Humanos , Masculino , Proteínas de Membrana/genética , Camundongos Endogâmicos C57BL , Camundongos Knockout , Mitocôndrias Cardíacas/patologia , Infarto do Miocárdio/genética , Infarto do Miocárdio/patologia , Traumatismo por Reperfusão Miocárdica/genética , Traumatismo por Reperfusão Miocárdica/patologia , Miócitos Cardíacos/patologia , Estabilidade Proteica , Proteólise , Transdução de SinaisRESUMO
Thrombolytic therapy and revascularization strategies create a complete recanalization of the occluded epicardial coronary artery in patients with myocardial infarction (MI). However, about 35 % of patients still experience an impaired myocardial reperfusion, which is termed a no-reflow phenomenon mainly caused by cardiac microvascular ischemia-reperfusion (I/R) injury. Mitochondria are essential for microvascular endothelial cells' survival, both because of their roles as metabolic energy producers and as regulators of programmed cell death. Mitochondrial structure and function are regulated by a mitochondrial quality control (MQC) system, a series of processes including mitochondrial biogenesis, mitochondrial dynamics/mitophagy, mitochondrial proteostasis, and mitochondria-mediated cell death. Our review discusses the MQC mechanisms and how they are linked to cardiac microvascular I/R injury. Additionally, we will summarize the molecular basis that results in defective MQC mechanisms and present potential therapeutic interventions for improving MQC in cardiac microvascular I/R injury.
Assuntos
Mitocôndrias Cardíacas/patologia , Dinâmica Mitocondrial , Mitofagia , Traumatismo por Reperfusão Miocárdica/patologia , Miócitos Cardíacos/patologia , Fenômeno de não Refluxo/patologia , Biogênese de Organelas , Animais , Apoptose , Fármacos Cardiovasculares/uso terapêutico , Circulação Coronária , Metabolismo Energético , Humanos , Microcirculação , Mitocôndrias Cardíacas/efeitos dos fármacos , Mitocôndrias Cardíacas/metabolismo , Dinâmica Mitocondrial/efeitos dos fármacos , Mitofagia/efeitos dos fármacos , Traumatismo por Reperfusão Miocárdica/tratamento farmacológico , Traumatismo por Reperfusão Miocárdica/metabolismo , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/metabolismo , Necrose , Fenômeno de não Refluxo/tratamento farmacológico , Fenômeno de não Refluxo/metabolismo , Fenômeno de não Refluxo/fisiopatologia , Transdução de Sinais , Resposta a Proteínas não DobradasRESUMO
Mitochondrial fission factor (Mff) has been demonstrated to play a role in the activation of mitochondrial cleavage and mitochondrial death, denoting its role in the regulation of mitochondrial quality control. Recent evidence suggested that the mRNA translation of Mff is under the negative regulation by the RNA-binding protein Pumilio2 (Pum2). This study was designed to examine the role of Pum2 and Mff in the governance of mitochondrial quality control in a murine model of acute ischemic kidney injury. Our results indicated that genetic deletion of Mff overtly attenuated ischemic acute kidney injury (AKI)-induced renal failure through inhibition of pro-inflammatory response, tubular oxidative stress, and ultimately cell death in the kidney. Furthermore, Mff inhibition effectively preserved mitochondrial homeostasis through amelioration of mitochondrial mitosis, restoration of Sirt1/3 expression, and boost of mitochondrial respiration. Western blot analysis revealed that levels of Pum2 were significantly downregulated by ischemic AKI, inversely coinciding with levels of Mff. Overexpression of Pum2 reduced ischemic AKI-mediated Mff upregulation and offered protection on renal tubules through modulation of mitochondrial quality control. Taken together, our data have unveiled the molecular mechanism of the Pum2-Mff axis in mitochondrial quality control in a mouse model of ischemic AKI. These data indicated the therapeutic potential of Pum2 activation and Mff inhibition in the management of ischemic AKI.
Assuntos
Injúria Renal Aguda/metabolismo , Rim/metabolismo , Mitocôndrias/metabolismo , Proteínas de Ligação a RNA/metabolismo , Animais , Masculino , Proteínas de Membrana/metabolismo , Camundongos Endogâmicos C57BL , Dinâmica Mitocondrial/fisiologia , Proteínas Mitocondriais/metabolismo , Mitofagia/fisiologia , Regulação para CimaRESUMO
Amine-basedcarbon-capture technologies have been shown to be energetically expensive and to cause significant environmental and epidemiological impacts due to their volatility. Bicarbonate formation from carbon dioxide's reaction with water has been suggested as an effective alternative for capturing CO2; however, the thermodynamics of this reaction are not well understood. This study experimentally determined the equilibrium constant of sodium bicarbonate (NaHCO3) decomposition to sodium, water, and carbon dioxide; the study also compared the equilibrium constant to theoretical calculations. Using a combination of experimentation and thermodynamic relationships, the unitless equilibrium constants of the forward and reverse reactions were calculated accurately (error <±9% and <±4%, respectively). Equilibrium data were calculated using enthalpy and entropy values of each component of NaHCO3 decomposition at temperatures ranging from 25 to 155°C respectively. These results offer more data essential to optimizing NaHCO3 use in environmentally friendly next-generation CO2-capture technologies.
Assuntos
Dióxido de Carbono/química , Modelos Químicos , Bicarbonato de Sódio/química , TermodinâmicaRESUMO
Mitochondrial fission and mitophagy are considered key processes involved in the pathogenesis of cardiac microvascular ischemia reperfusion (IR) injury although the upstream regulatory mechanism for fission and mitophagy still remains unclear. Herein, we reported that NR4A1 was significantly upregulated following cardiac microvascular IR injury, and its level was positively correlated with microvascular collapse, endothelial cellular apoptosis and mitochondrial damage. However, NR4A1-knockout mice exhibited resistance against the acute microvascular injury and mitochondrial dysfunction compared with the wild-type mice. Functional studies illustrated that IR injury increased NR4A1 expression, which activated serine/threonine kinase casein kinase2 α (CK2α). CK2α promoted phosphorylation of mitochondrial fission factor (Mff) and FUN14 domain-containing 1 (FUNDC1). Phosphorylated activation of Mff enhanced the cytoplasmic translocation of Drp1 to the mitochondria, leading to fatal mitochondrial fission. Excessive fission disrupted mitochondrial function and structure, ultimately triggering mitochondrial apoptosis. In addition, phosphorylated inactivation of FUNDC1 failed to launch the protective mitophagy process, resulting in the accumulation of damaged mitochondria and endothelial apoptosis. By facilitating Mff-mediated mitochondrial fission and FUNDC1-required mitophagy, NR4A1 disturbed mitochondrial homeostasis, enhanced endothelial apoptosis and provoked microvascular dysfunction. In summary, our data illustrated that NR4A1 serves as a novel culprit factor in cardiac microvascular IR injury that operates through synchronous elevation of fission and suppression of mitophagy. Novel therapeutic strategies targeting the balance among NR4A1, fission and mitophagy might provide survival advantage to microvasculature following IR stress.
Assuntos
Caseína Quinase II/metabolismo , Vasos Coronários/enzimologia , Proteínas de Membrana/metabolismo , Microvasos/enzimologia , Mitocôndrias Cardíacas/enzimologia , Dinâmica Mitocondrial , Proteínas Mitocondriais/metabolismo , Mitofagia , Traumatismo por Reperfusão Miocárdica/enzimologia , Membro 1 do Grupo A da Subfamília 4 de Receptores Nucleares/metabolismo , Animais , Apoptose , Permeabilidade Capilar , Caseína Quinase II/genética , Células Cultivadas , Vasos Coronários/patologia , Vasos Coronários/fisiopatologia , Modelos Animais de Doenças , Dinaminas/metabolismo , Células Endoteliais/enzimologia , Células Endoteliais/patologia , Predisposição Genética para Doença , Masculino , Proteínas de Membrana/genética , Camundongos Knockout , Microvasos/patologia , Microvasos/fisiopatologia , Mitocôndrias Cardíacas/patologia , Proteínas Mitocondriais/genética , Traumatismo por Reperfusão Miocárdica/genética , Traumatismo por Reperfusão Miocárdica/patologia , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Membro 1 do Grupo A da Subfamília 4 de Receptores Nucleares/deficiência , Membro 1 do Grupo A da Subfamília 4 de Receptores Nucleares/genética , Fosforilação , Transporte Proteico , Transdução de Sinais , VasodilataçãoRESUMO
The molecular features of necroptosis in cardiac ischemia-reperfusion (IR) injury have been extensively explored. However, there have been no studies investigating the physiological regulatory mechanisms of melatonin acting on necroptosis in cardiac IR injury. This study was designed to determine the role of necroptosis in microvascular IR injury, and investigate the contribution of melatonin in repressing necroptosis and preventing IR-mediated endothelial system collapse. Our results demonstrated that Ripk3 was primarily activated by IR injury and consequently aggravated endothelial necroptosis, microvessel barrier dysfunction, capillary hyperpermeability, the inflammation response, microcirculatory vasospasms, and microvascular perfusion defects. However, administration of melatonin prevented Ripk3 activation and provided a pro-survival advantage for the endothelial system in the context of cardiac IR injury, similar to the results obtained via genetic ablation of Ripk3. Functional investigations clearly illustrated that activated Ripk3 upregulated PGAM5 expression, and the latter increased CypD phosphorylation, which obligated endothelial cells to undergo necroptosis via augmenting mPTP (mitochondrial permeability transition pore) opening. Interestingly, melatonin supplementation suppressed mPTP opening and interrupted endothelial necroptosis via blocking the Ripk3-PGAM5-CypD signal pathways. Taken together, our studies identified the Ripk3-PGAM5-CypD-mPTP axis as a new pathway responsible for reperfusion-mediated microvascular damage via initiating endothelial necroptosis. In contrast, melatonin treatment inhibited the Ripk3-PGAM5-CypD-mPTP cascade and thus reduced cellular necroptosis, conferring a protective advantage to the endothelial system in IR stress. These findings establish a new paradigm in microvascular IR injury and update the concept for cell death management handled by melatonin under the burden of reperfusion attack.
Assuntos
Vasos Coronários/metabolismo , Ciclofilinas/metabolismo , Melatonina/farmacologia , Microvasos/metabolismo , Proteínas de Transporte da Membrana Mitocondrial/metabolismo , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Fosfoproteínas Fosfatases/metabolismo , Proteína Serina-Treonina Quinases de Interação com Receptores/metabolismo , Transdução de Sinais/efeitos dos fármacos , Animais , Vasos Coronários/patologia , Peptidil-Prolil Isomerase F , Ciclofilinas/genética , Camundongos , Camundongos Knockout , Microvasos/patologia , Proteínas de Transporte da Membrana Mitocondrial/genética , Poro de Transição de Permeabilidade Mitocondrial , Traumatismo por Reperfusão Miocárdica/genética , Traumatismo por Reperfusão Miocárdica/metabolismo , Traumatismo por Reperfusão Miocárdica/patologia , Fosfoproteínas Fosfatases/genética , Proteína Serina-Treonina Quinases de Interação com Receptores/genéticaRESUMO
Gasification is one of the most promising approaches to accomplishing efficient utilization of biomass, nevertheless, it shows severe problems of low efficiency and syngas quality, which deserves further improvements. In this regard, deoxygenation-sorption-enhanced biomass gasification is proposed and experimentally explored using deoxidizer-decarbonizer materials (xCaO-Fe) for intensified hydrogen production. The materials follow the deoxygenated looping of Fe0-3e-âFe3+ as an electron donor and the decarbonized looping of CaO + CO2 â CaCO3 as a CO2 sorbent. Specifically, the H2 yield and CO2 concentration reach 7.9 mmol·g-1 biomass and 10.5 vol%, which increases by 311% and decreases by 75%, respectively, compared with conventional gasification, confirming the promotion effect of deoxygenation-sorption enhancement. Fe embedded within the CaO phase is successfully constructed with the formation of functionalized interface structure, affirming the strong interaction between CaO and Fe. This study brings in a new concept for biomass utilization via synergistic deoxygenation and decarbonization, which will substantially boost high-quality renewable hydrogen production.
Assuntos
Dióxido de Carbono , Hidrogênio , Dióxido de Carbono/química , BiomassaRESUMO
High energy consumption and high cost have been the obstacles for large-scale deployment of all state-of-the-art CO2 capture technologies. Finding a transformational way to improve mass transfer and reaction kinetics of the CO2 capture process is timely for reducing carbon footprints. In this work, commercial single-walled carbon nanotubes (CNTs) were activated with nitric acid and urea under ultrasonication and hydrothermal methods, respectively, to prepare N-doped CNTs with the functional group of -COOH, which possesses both basic and acid functionalities. The chemically modified CNTs with a concentration of 300 ppm universally catalyze both CO2 sorption and desorption of the CO2 capture process. The increases in the desorption rate achieved with the chemically modified CNTs can reach as high as 503% compared to that of the sorbent without the catalyst. A chemical mechanism underlying the catalytic CO2 capture is proposed based on the experimental results and further confirmed by density functional theory computations.
RESUMO
Despite considerable efforts to prevent and treat ischemic cardiomyopathy (ICM), effective therapies remain lacking, in part owing to the complexity of the underlying molecular mechanisms, which are not completely understood yet. It is now widely thought that mitochondria serve as "sentinel" organelles that are capable of detecting cellular injury and integrating multiple stress signals. These pathophysiological activities are temporally and spatially governed by the mitochondrial quality surveillance (MQS) system, involving mitochondrial dynamics, mitophagy, and biogenesis. Dysregulation of MQS is an early and critical process contributing to mitochondrial bioenergetic dysfunction and sublethal injury to cardiomyocytes during ICM. An improved understanding of the pathogenesis of ICM may enable the development of novel preventive and therapeutic strategies aimed at overcoming the challenge of myocardial ischemia and its cardiovascular sequelae. This review describes recent research on the protective effects of MQS in ICM and highlights promising therapeutic targets.
Assuntos
Cardiomiopatias , Isquemia Miocárdica , Cardiomiopatias/etiologia , Cardiomiopatias/terapia , Humanos , Mitocôndrias/patologia , Dinâmica Mitocondrial , Mitofagia , Isquemia Miocárdica/patologiaRESUMO
The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) regulates cell death. We sought to determine whether DNA-PKcs played a role in the tubular damage that occurs during acute kidney injury (AKI) induced by LPS injection (to mimic sepsis), cisplatin administration, or renal ischemia/reperfusion injury. Although DNA-PKcs normally localizes to the nucleus, we detected cytoplasmic DNA-PKcs in mouse kidney tissues and urinary sediments of human patients with septic AKI. Increased cytoplasmic amounts of DNA-PKcs correlated with renal dysfunction. Tubule cell-specific DNA-PKcs deletion attenuated AKI-mediated tubular cell death and changes in the abundance of various proteins with mitochondrial functions or roles in apoptotic pathways. DNA-PKcs interacted with Fis1 and phosphorylated it at Thr34 in its TQ motif, which increased the affinity of Fis1 for Drp1 and induced mitochondrial fragmentation. Knockin mice expressing a nonphosphorylatable T34A mutant exhibited improved renal function and histological features and reduced mitochondrial fragmentation upon induction of AKI. Phosphorylation of Thr34 in Fis1 was detectable in urinary sediments of human patients with septic AKI and correlated with renal dysfunction. Our findings provide insight into the role of cytoplasmic DNA-PKcs and phosphorylated Fis1 in AKI development.
Assuntos
Injúria Renal Aguda , Proteínas Quinases , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/genética , Injúria Renal Aguda/metabolismo , Animais , DNA/metabolismo , Humanos , Rim/metabolismo , Proteínas de Membrana/metabolismo , Camundongos , Mitocôndrias/metabolismo , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Proteínas Quinases/metabolismoRESUMO
Mitophagy preserves microvascular structure and function during myocardial ischemia/reperfusion (I/R) injury. Empagliflozin, an anti-diabetes drug, may also protect mitochondria. We explored whether empagliflozin could reduce cardiac microvascular I/R injury by enhancing mitophagy. In mice, I/R injury induced luminal stenosis, microvessel wall damage, erythrocyte accumulation and perfusion defects in the myocardial microcirculation. Additionally, I/R triggered endothelial hyperpermeability and myocardial neutrophil infiltration, which upregulated adhesive factors and endothelin-1 but downregulated vascular endothelial cadherin and endothelial nitric oxide synthase in heart tissue. In vitro, I/R impaired the endothelial barrier function and integrity of cardiac microvascular endothelial cells (CMECs), while empagliflozin preserved CMEC homeostasis and thus maintained cardiac microvascular structure and function. I/R activated mitochondrial fission, oxidative stress and apoptotic signaling in CMECs, whereas empagliflozin normalized mitochondrial fission and fusion, neutralized supraphysiologic reactive oxygen species concentrations and suppressed mitochondrial apoptosis. Empagliflozin exerted these protective effects by activating FUNDC1-dependent mitophagy through the AMPKα1/ULK1 pathway. Both in vitro and in vivo, genetic ablation of AMPKα1 or FUNDC1 abolished the beneficial effects of empagliflozin on the myocardial microvasculature and CMECs. Taken together, the preservation of mitochondrial function through an activation of the AMPKα1/ULK1/FUNDC1/mitophagy pathway is the working mechanism of empagliflozin in attenuating cardiac microvascular I/R injury.
Assuntos
Mitofagia , Traumatismo por Reperfusão Miocárdica , Animais , Compostos Benzidrílicos , Células Endoteliais/metabolismo , Glucosídeos , Isquemia/metabolismo , Proteínas de Membrana/metabolismo , Camundongos , Proteínas Mitocondriais/metabolismo , Mitofagia/fisiologia , Traumatismo por Reperfusão Miocárdica/metabolismo , ReperfusãoRESUMO
INTRODUCTION: Multiple organ failure is the commonest cause of death in septic patients. OBJECTIVES: This study was undertaken in an attempt to elucidate the functional importance of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) on mitochondrial dysfunction associated with the development and progression of sepsis-related multiple organ dysfunction syndrome (MODS). METHODS: Cardiomyocyte-specific DNA-PKcs knockout (DNA-PKcsCKO) mice, liver-specific DNA-PKcs knockout (DNA-PKcsLKO) mice, and kidney tubular cell-specific DNA-PKcs knockout (DNA-PKcsTKO) mice were used to generate an LPS-induced sepsis model. Echocardiography, serum biochemistry, and tissue microscopy were used to analyze organ damage and morphological changes induced by sepsis. Mitochondrial function and dynamics were determined by qPCR, western blotting, ELISA, and mt-Keima and immunofluorescence assays following siRNA-mediated DNA-PKCs knockdown in cardiomyocytes, hepatocytes, and kidney tubular cells. RESULTS: DNA-PKcs deletion attenuated sepsis-mediated myocardial damage through improving mitochondrial metabolism. Loss of DNA-PKcs protected the liver against sepsis through inhibition of mitochondrial oxidative damage and apoptosis. DNA-PKcs deficiency sustained kidney function upon LPS stress through normalization of mitochondrial fission/fusion events, mitophagy, and biogenesis. CONCLUSION: We conclude that strategies targeting DNA-PKcs expression or activity may be valuable therapeutic options to prevent or reduce mitochondrial dysfunction and organ damage associated with sepsis-induced MODS.